| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/01/2000 | CN1245691A Chinese plaster for curing liver diseases and its preparation method |
| 03/01/2000 | CN1245689A Preparation method of bee afterbirth extract (bee frison extract) and its application |
| 03/01/2000 | CN1245684A Albendazole suspensoid emulsion its preparation method |
| 03/01/2000 | CN1049836C Process for extracting red sage root injection |
| 03/01/2000 | CN1049834C Medicine for curing hepatitis and its prepn. process |
| 03/01/2000 | CN1049831C Plaster for curing hyperosteogeny |
| 03/01/2000 | CN1049820C Etoposide preparations |
| 03/01/2000 | CN1049817C Method for preparation of percutaneously absorbable drug composition |
| 03/01/2000 | CN1049816C Process for preparing stock aqueous suspension of sucralfate |
| 02/29/2000 | US6031043 Topical composition comprising a hydrophilic gelling agent of polyester sulphone type |
| 02/29/2000 | US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale |
| 02/29/2000 | US6031004 Metformin (2:1) fumarate and metformin (2:1) succinate; antidiabetic and hypoglycemic agents; improved handling, i.e. lower hygroscopicity, free-flowing, reduced compaction susceptibiity, corrosion resistance; improved taste |
| 02/29/2000 | US6030998 Using a parenteral solution of amiodarone free of any tween surfactant and having a ph of 3.5-4.0 at a concentration of about 10-50 mg/ml; side effect reduction; storage stability; nonsettling |
| 02/29/2000 | US6030988 Immediate release pH-independent solid dosage form of cisapride |
| 02/29/2000 | US6030958 Combining in aqueous solution, polyanionic polysaccharide selected from carboxymethylcellulose and carboxymethylamylose and carbodimide in acidic conditions |
| 02/29/2000 | US6030953 For preventing and treating anal leakage of oil in a patient |
| 02/29/2000 | US6030837 Antisense inhibition of PEPCK-mitochondrial expression |
| 02/29/2000 | US6030682 Container for aerosol formulation |
| 02/29/2000 | US6030645 Free-flowing dry particles |
| 02/29/2000 | US6030644 Sustained-release granular preparations and production process thereof |
| 02/29/2000 | US6030643 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 02/29/2000 | US6030642 Extended release clonidine formulation (capsule) |
| 02/29/2000 | US6030641 Sustained release capsule and method for preparing the same |
| 02/29/2000 | US6030639 Treatment using prostoglandin and particulate formulations |
| 02/29/2000 | US6030638 Plasmid for in vivo expression of prostaglandin synthase |
| 02/29/2000 | US6030637 Pellet for administration to ruminants |
| 02/29/2000 | US6030636 Calcium sulfate controlled release matrix |
| 02/29/2000 | US6030634 Polymer gel composition and uses therefor |
| 02/29/2000 | US6030633 Film-forming compositions for protecting animal skin |
| 02/29/2000 | US6030631 Device and method for decreasing nausea and vomiting |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030605 Breath freshening compositions and methods using them |
| 02/29/2000 | US6030604 Formulation for inhalation |
| 02/29/2000 | US6030603 Emulsions as contrast agents and method of use |
| 02/29/2000 | US6030602 Peptide conjugates for transfecting cells |
| 02/29/2000 | US6030375 Compressible vaginal insert and method for treating urogenital disorders |
| 02/29/2000 | CA2248592A1 Microspheres for use in the treatment of cancer |
| 02/29/2000 | CA2149940C Patch-type device for transdermal delivery of insulin |
| 02/29/2000 | CA2050072C Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 02/29/2000 | CA2046739C Coated solid medicament form having releasability in large intestine |
| 02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
| 02/24/2000 | WO2000009672A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000009652A2 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 02/24/2000 | WO2000009639A2 Fatty ester combinations |
| 02/24/2000 | WO2000009566A1 Method for producing ultra-pure alginates |
| 02/24/2000 | WO2000009179A2 Methods, instruments and materials for chondrocyte cell transplantation |
| 02/24/2000 | WO2000009171A1 Products containing unpleasant tasting bio-affecting agents and methods of making them |
| 02/24/2000 | WO2000009162A1 Preventives/remedies for glaucoma |
| 02/24/2000 | WO2000009158A1 Assay for assembly of herpes simplex virus capsid |
| 02/24/2000 | WO2000009134A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 02/24/2000 | WO2000009133A1 Sustained release oral preparations of fasudil hydrochloride |
| 02/24/2000 | WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 02/24/2000 | WO2000009122A1 Pharmaceutical compositions containing lipase inhibitors |
| 02/24/2000 | WO2000009117A1 Nimesulide containing topical pharmaceutical compositions |
| 02/24/2000 | WO2000009097A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 02/24/2000 | WO2000009096A1 Injectable formulations of nanoparticulate naproxen |
| 02/24/2000 | WO2000009095A1 Organoleptically pleasant in-mouth rapidly disintegrable potassium chloride tablet |
| 02/24/2000 | WO2000009093A1 Microemulsions as solid dosage forms for oral administration |
| 02/24/2000 | WO2000009092A1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 02/24/2000 | WO2000009091A1 Once daily analgesic tablet |
| 02/24/2000 | WO2000009090A1 Orally disintegrable tablet forming a viscous slurry |
| 02/24/2000 | WO2000009089A1 Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 02/24/2000 | WO2000009088A1 Composite hydrogel drug delivery systems |
| 02/24/2000 | WO2000009087A1 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009085A2 Oral formulation containing cyclosporin |
| 02/24/2000 | WO2000009084A2 Biodegradable microparticles gel composition |
| 02/24/2000 | WO2000009072A2 Disintegratable microspheres |
| 02/24/2000 | WO2000009071A2 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases |
| 02/24/2000 | WO2000009037A1 Material delivery devices and methods |
| 02/24/2000 | WO2000001372A3 Chewable oral unit dosage |
| 02/24/2000 | WO1999066949A3 An antimicrobial effective against gram-positive pathogens |
| 02/24/2000 | WO1999065461A3 Cationic amphiphile micellar complexes |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | WO1999062504A3 Topical administration of oxazolidinones for transdermal delivery |
| 02/24/2000 | WO1999059638A3 Compositions and methods for the delivery of nucleic acid molecules |
| 02/24/2000 | DE19837684A1 Tablet comprises two faces, mantle surface, non-planar surfaces and breakage grooves on each face |
| 02/24/2000 | DE19834007C1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung Estradiolhaltiges patch for transdermal administration of hormones and its use |
| 02/24/2000 | DE19834006A1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen Estradiolhaltiges patch for transdermal administration of hormones |
| 02/24/2000 | CA2553126A1 Oral sustained-release preparation of fasudil hydrochloride |
| 02/24/2000 | CA2340322A1 Dnazymes and methods for treating restenosis |
| 02/24/2000 | CA2340177A1 Biodegradable microparticles gel composition |
| 02/23/2000 | EP0980376A1 Method for producing carbohydrate partial esters |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980262A1 Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980248A1 Improvements in or relating to long-acting antimicrobials |
| 02/23/2000 | EP0980245A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction |
| 02/23/2000 | EP0980241A1 Gelatine encapsulated solution dosage forms of sertraline |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | EP0980215A1 Encapsulated material with controlled release |
| 02/23/2000 | EP0980203A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 02/23/2000 | EP0980202A1 Methods for viral inactivation and compositions for use in same |
| 02/23/2000 | EP0935425A4 Fat-coated encapsulation compositions and method for preparing the same |
| 02/23/2000 | CN1245436A Pharmaceutical formulations for sustained drug delivery |
| 02/23/2000 | CN1245435A Pharmaceutical compositions containing gellants in form of alkyl amides of di- and tri-carboxylic acids |
| 02/23/2000 | CN1245434A Stable liquid interferon formulations |
| 02/23/2000 | CN1245431A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation |
| 02/23/2000 | CN1245430A Prophylactic and therapeutic agent for inflammatory intestinal diseases |